|
Home Page
About SAEN
Articles and Reports
Contact Us
Events and Campaigns
Fact Sheets
Financial Information
How You Can Help
Make a Donation, Please!
Media Coverage
Newsletters
Petitions
Picture Archive
Press Releases
Resources and Links
Grass Roots Org. List



|
Stop Animal
Exploitation NOW!
S. A. E. N.
"Exposing the truth to wipe
out animal experimentation"

Government Grants Promoting Cruelty to Animals
University of Texas at San Antonio, San Antonio, TX
CHARLES P. FRANCE - Primate Testing - 2006
Grant Number: 5R01DA009157-12
Project Title: Discriminative effects of benzodiazepine
withdrawal
PI Information: PROFESSOR CHARLES P. FRANCE,
france@uthscsa.edu
Abstract: Benzodiazepines and related gamma-amino butyric acid (GABA)A
modulators are used widely for their anxiolytic, hypnotic and anti-
convulsant effects. These same compounds are also abused, both alone and
in combination with other classes of drugs (e.g., opioids), and long-
term use of benzodiazepines can lead to clinically significant physical
dependence. The GABAA receptor complex is the site of action of other
drugs of abuse (e.g., ethanol) and GABAergic systems, in general, are
thought to indirectly modulate the effects of still other drugs of abuse
(e.g., cocaine). Much has been learned over the past 10 years from
molecular studies on GABA receptors, yet little of this knowledge has
been applied to studies in behaving organisms, particularly with regard
to GABA neurobiology and substance abuse. Procedures have been developed
under this grant for studying discriminative stimulus effects of GABAA
modulators in rhesus monkeys and studies proposed in this application
will use those procedures to investigate the neurobiology of drugs that
vary in their actions on GABAergic systems. Studies under Aim 1ill will
compare GABAergic and other drugs for their ability to prevent and
reverse benzodiazepine withdrawal and also to mimic the subjective
(discriminative) effects of benzodiazepine in normal subjects. A
parallel study (Aim II) will establish a discrimination with flumazenil
in monkeys treated daily with the a1-s3lective positive modulator
zolpidem to test whether this widely-prescribed sedative/hypnotic
produces dependence that can be differentiated from that produced by
diazepam.Neuroactive steroids will be studied under Aim III to see
whether th eye modify the behavioral effects of other compounds that act
at the GABAA receptor complex. This study is founded on positive
preliminary data with pregnanolone and a literature showing that
neuroactive steroids uncouple benzodiazepine receptors from the GABAA
receptor complex in vitro. Blind evaluation of compounds will continue
the auspices of the Drug Evaluation Committee of the College on Drug
Dependence under Aim IV. Collectively, these studies will provide
important quantitative information on the nature of drug/receptor and
drug/drug interactions for GABAA modulators and related drugs. These
data will promote an understanding of GABAergic neurotransmission and
abuse liability for a variety of clinically relevant compounds.
Thesaurus Terms:
benzodiazepine, drug addiction, drug screening /evaluation, drug
withdrawal, psychopharmacology GABA receptor, benzodiazepine receptor,
diazepam, drug addiction antagonist, drug interaction, drug tolerance,
midazolam, neural transmission, neurobiology, neurohormone, receptor
coupling, receptor sensitivity, sedative /hypnotic, substance abuse
related behavior Macaca mulatta, behavior test
Institution: UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
SAN ANTONIO, TX 78229
Fiscal Year: 2006
Department: PHARMACOLOGY
Project Start: 15-MAR-1995
Project End: 31-JAN-2008
ICD: NATIONAL INSTITUTE ON DRUG ABUSE
IRG: ZRG1
Efficacy and the Discriminative Stimulus Effects of
Negative GABAA Modulators, or Inverse Agonists, in Diazepam-Treated
Rhesus Monkeys
Lance R. McMahon, Lisa R. Gerak, and Charles P. France
Departments of Pharmacology (L.R.M., L.R.G., C.P.F.) and Psychiatry (C.P.F.),
the University of Texas Health Science Center at San Antonio, San
Antonio, Texas
Received February 17, 2006; accepted May 15, 2006.
JPET 318:907-913, 2006
Subjects. One female and five male adult rhesus monkeys were
housed individually on a 14-h light/10-h dark schedule, were maintained
at 95% free-feeding weight (range 8.0-11 kg) with a diet comprising
primate chow (Harlan Teklad, High Protein Monkey Diet; Harlan Teklad,
Madison, WI), fresh fruit, and peanuts, and were provided water in the
home cage. Monkeys received 5.6 mg/kg/day diazepam, were trained to
discriminate flumazenil, and had received GABAA ligands in previous
studies (McMahon and France, 2005 ). The animals used in these studies
were maintained in accordance with the Institutional Animal Care and Use
Committee, The University of Texas Health Science Center at San Antonio,
San Antonio, TX, and with the 1996 Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory Animal Resources on Life
Sciences, National Research Council, National Academy of Sciences).
Apparatus. During experimental sessions, monkeys were seated in
chairs (model R001; Primate Products, Miami, FL) that provided restraint
at the neck and were placed in ventilated, sound-attenuating chambers
equipped with two response levers, stimulus lights, and a food cup to
which pellets (Bio-Serv, Frenchtown, NJ) could be delivered from a
dispenser. An interface (MedAssociates, St. Albans, VT) connected the
chambers to a computer that controlled and recorded experimental events.
Discrimination Procedure. Monkeys drank a solution containing
diazepam (5.6 mg/kg) 3 h before experimental sessions consisting of
multiple 15-min cycles. Each cycle comprised a 10-min timeout period,
during which responses had no programmed consequence, followed by a
5-min response period, during which green stimulus lights were
illuminated and a fixed ratio (FR) 5 schedule of food presentation was
in effect. A maximum of 10 food pellets was available during a cycle;
when the maximal number of food pellets was obtained in <5 min, the
remainder of the response period was a timeout. The selection of
vehicle- and flumazenil-appropriate levers varied among monkeys and
remained the same for an individual throughout the study. Responding on
the incorrect lever reset the response requirement on the correct lever. |
Please email: CHARLES P.
FRANCE, france@uthscsa.edu
to protest the inhumane use of animals in this
experiment. We would also love to know about your efforts with this
cause:
saen@saenonline.org
Return to Grants
Return to University of Texas at San Antonio, San Antonio, TX
Return to Facility Reports and Information
Return to Resources and Links
Rats, mice, birds, amphibians and other animals have
been excluded from coverage by the Animal Welfare Act. Therefore research
facility reports do not include these animals. As a result of this
situation, a blank report, or one with few animals listed, does not mean
that a facility has not performed experiments on non-reportable animals. A
blank form does mean that the facility in question has not used covered
animals (primates, dogs, cats, rabbits, guinea pigs, hamsters, pigs,
sheep, goats, etc.). Rats and mice alone are believed to comprise over 90%
of the animals used in experimentation. Therefore the majority of animals
used at research facilities are not even counted.
|